The Danish Myelodysplastic Syndromes Database: Patient Characteristics and Validity of Data Records

References

• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-64354427069254
   PubMed Web of Science ®Google Scholar
• Stephen H, Swerdlow EC, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization; 2017.
   Google Scholar
• Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs. Blood. 2008;112(1):45–52. doi:10.1182/blood-2008-01-13485818443215
   PubMed Web of Science ®Google Scholar
• Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109(8):1536–1542. doi:10.1002/cncr.2257017345612
   PubMed Web of Science ®Google Scholar
• Zeidan AM, Shallis RM, Wang R, Davidoff A, Ma X. Epidemiology of myelodysplastic syndromes: why characterizing the beast is a prerequisite to taming it. Blood Rev. 2019;34:1–15. doi:10.1016/j.blre.2018.09.00130314642
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S17908331372058
   PubMed Web of Science ®Google Scholar
• Akut Leukæmi Gruppen, annual report 2018. Available from: www.hematology.dk/index.php/om-alg/arsrapporter. Accessed 430, 2021.
   Google Scholar
• Simons A, Shaffer LG, Hastings RJ. Cytogenetic nomenclature: changes in the ISCN 2013 Compared to the 2009 Edition. Cytogenet Genome Res. 2013;141(1):1–6. doi:10.1159/00035311823817294
   PubMed Web of Science ®Google Scholar
• Nørgaard M, Johnsen SP. How can the research potential of the clinical quality databases be maximized? The Danish experience. J Intern Med. 2016;279(2):132–140. doi:10.1111/joim.1243726785952
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Arendt JFH, Hansen AT, Ladefoged SA, Sørensen HT, Pedersen L, Adelborg K. Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol. 2020;12:469–475. doi:10.2147/CLEP.S24506032547238
   PubMed Web of Science ®Google Scholar
• Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39(7 Suppl):72–74. doi:10.1177/140349481039356321775357
   PubMed Web of Science ®Google Scholar
• Statistics Denmark. Available from: https://www.statbank.dk/statbank5a/default.asp?w=1366. Accessed 430, 2021.
   Google Scholar
• Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.10320831078660
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.01018929686
   PubMed Web of Science ®Google Scholar
• Moreno Berggren D, Folkvaljon Y, Engvall M, et al. Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register. Br J Haematol. 2018;181(5):614–627. doi:10.1111/bjh.1524329707769
   PubMed Web of Science ®Google Scholar
• Neukirchen J, Schoonen WM, Strupp C, et al. Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry. Leuk Res. 2011;35(12):1591–1596. doi:10.1016/j.leukres.2011.06.00121708407
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Schoonen WM, Kantarjian H, et al. Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst. 2008;100(21):1542–1551. doi:10.1093/jnci/djn34918957672
   PubMedGoogle Scholar
• The Danish Transfusion Database. Available from: https://www.rkkp.dk/om-rkkp/de-kliniske-kvalitetsdatabaser/transfusionsdatabase/. Accessed 430, 2021.
   Google Scholar
• Ostgård LS, Nørgaard JM, Severinsen MT, et al. Data quality in the Danish National Acute Leukemia Registry: a hematological data resource. Clin Epidemiol. 2013;5:335–344. doi:10.2147/CLEP.S4841124039451
   PubMedGoogle Scholar
• Ma X, Steensma DP, Scott BL, Kiselev P, Sugrue MM, Swern AS. Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States. BMJ Open. 2018;8(7):e019955. doi:10.1136/bmjopen-2017-019955
   Web of Science ®Google Scholar
• Arboe B, Josefsson P, Jørgensen J, et al. Danish National Lymphoma Registry. Clin Epidemiol. 2016;8:577–581. doi:10.2147/CLEP.S9947027822102
   PubMed Web of Science ®Google Scholar
• Arboe B, El-Galaly TC, Clausen MR, et al. The Danish National Lymphoma Registry: coverage and Data Quality. PLoS One. 2016;11(6):e0157999. doi:10.1371/journal.pone.015799927336800
   PubMed Web of Science ®Google Scholar
• Tanaka TN, Bejar R. MDS overlap disorders and diagnostic boundaries. Blood. 2019;133(10):1086–1095. doi:10.1182/blood-2018-10-84467030670443
   PubMed Web of Science ®Google Scholar
• Steensma DP. Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors. Curr Hematol Malig Rep. 2012;7(4):310–320. doi:10.1007/s11899-012-0140-323015360
   PubMed Web of Science ®Google Scholar
• Malcovati L, Cazzola M. The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP). Hematology Am Soc Hematol Educ Program. 2015;2015:299–307. doi:10.1182/asheducation-2015.1.29926637737
   PubMed Web of Science ®Google Scholar
• Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9–16. doi:10.1182/blood-2015-03-63174725931582
   PubMed Web of Science ®Google Scholar
• Valent P. ICUS, IDUS, CHIP and CCUS: diagnostic criteria, separation from MDS and clinical implications. Pathobiology. 2019;86(1):30–38. doi:10.1159/00048904229860246
   PubMed Web of Science ®Google Scholar
• Valent P, Orazi A, Steensma DP, et al. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions. Oncotarget. 2017;8(43):73483–73500. doi:10.18632/oncotarget.1900829088721
   PubMedGoogle Scholar
• Nationell rapport från kvalitetsregistret Myelodysplastiskt syndrom. Rapport för diagnosår 2009–2017. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/blod-lymfom-myelom/myelodysplastiskt-syndrom-mds/kvalitetsregister/rapporter/. Accessed 430, 2021.
   Google Scholar
• Cheson BD, Greenberg PL, Bennett JM, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006;108(2):419–425. doi:10.1182/blood-2005-10-414916609072
   PubMed Web of Science ®Google Scholar
• Platzbecker U, Fenaux P, Adès L, et al. Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials. Blood. 2019;133(10):1020–1030. doi:10.1182/blood-2018-06-85710230404811
   PubMed Web of Science ®Google Scholar
• Broe MO, Jensen PB, Mattsson TO, Pottegård A. Validity of antineoplastic procedure codes in the Danish national patient registry: the case of colorectal cancer. Epidemiology. 2020;31(4):599–603. doi:10.1097/EDE.000000000000120832483069
   PubMed Web of Science ®Google Scholar
• Østgård LSG, Lund JL, Nørgaard JM, et al. Impact of allogeneic stem cell transplantation in first complete remission in acute myeloid leukemia: a National Population-Based Cohort Study. Biol Blood Marrow Transplant. 2018;24(2):314–323. doi:10.1016/j.bbmt.2017.10.01929051022
   PubMed Web of Science ®Google Scholar